Prognostic significance of inflammatory markers in patients with advanced renal cell carcinoma receiving nivolumab plus ipilimumab
Takayuki Nakayama, Hideki Takeshita, Makoto Kagawa, Satoshi Washino, Suguru Shirotake, Yuji Miura, Yoji Hyodo, Keita Izumi, Masaharu Inoue, Yoh Matsuoka, Tomoaki Miyagawa, Masafumi Oyama, Kazutaka Saito, Satoru Kawakami
Topics & Concepts
MedicineNivolumabSurgical oncologyIpilimumabRenal cell carcinomaInternal medicineOncologyImmunotherapyCancerInflammatory Biomarkers in Disease PrognosisRenal cell carcinoma treatmentCancer Immunotherapy and Biomarkers